Akums Drugs and Pharmaceutical (AKUMS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 317.28 328.35 337.41 328.75 332.44 309.32 368.61 338.37
YOY Revenue Growth % - - - - 4.78% -5.8% 9.25% 2.93%
Other Income 26.18 32.12 33.84 32.05 28.56 27.08 29.60 27.73
Total Income 343.45 360.47 371.25 360.80 361.00 336.39 398.21 366.10
Total Expenses + 285.77 291.35 295.53 323.75 301.49 305.19 358.54 341.60
Cost of Materials Consumed 200.90 196.47 206.62 207.06 192.55 202.31 222.67 212.81
Employee Benefit Expense 47.18 50.38 50.34 53.84 50.74 54.58 54.80 57.88
Other Expenses 37.69 44.51 38.56 49.78 42.77 46.63 54.75 62.04
Operating Profit 31.50 37.00 41.88 5.01 30.95 4.12 10.07 -3.23
OPM % 9.9% 11.3% 12.4% 1.5% 9.3% 1.3% 2.7% -1%
Profit Before Tax + 54.27 61.62 54.89 37.06 59.51 31.20 35.87 21.79
Tax Expense 12.40 11.25 13.72 9.47 14.64 7.74 7.75 6.59
Tax % 22.8% 18.3% 25% 25.5% 24.6% 24.8% 21.6% 30.3%
Profit After Tax 41.88 50.37 41.17 27.59 44.87 23.46 28.11 15.20
EPS (Basic) 2.93 3.38 2.69 1.80 2.93 1.53 1.84 0.99

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 1,311.78
YOY Revenue Growth % -
Other Income 124.19
Total Income 1,435.98
Total Expenses + 1,228.14
Cost of Materials Consumed 811.06
Employee Benefit Expense 201.74
Other Expenses 170.54
Operating Profit 83.65
OPM % 6.4%
Profit Before Exceptional 207.84
Exceptional Items 0.00
Profit Before Tax + 207.84
Tax Expense 46.84
Tax % 22.5%
Profit After Tax 161.00
EPS (Basic) 10.76

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 1,851.73
Property, Plant & Equipment 334.92
Capital Work in Progress 53.71
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 2.60
Current Assets + 833.18
Inventories 201.69
Trade Receivables 206.14
Cash and Cash Equivalents 76.49
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 30.62
Other Equity 2,274.63
Non-Current Liabilities 70.36
Current Liabilities 309.31
Total Liabilities 379.66

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 91.00
Cash from Investing Activities -458.84
Cash from Financing Activities 375.38
Net Increase/Decrease in Cash 7.54